Enveric Biosciences, Inc. (ENVB) stock
ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.52+0.03 (+2.01%)
Close on Nov 12, 2026Market cap $6.80MP/E –Yield –
Enveric Biosciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Enveric Biosciences's total debt was $1.00M at Mar 31, 2020. For fiscal 2019 it was $4.88M, down 6.4% from the year before. The highest annual figure on record is $6.68M in fiscal 2017.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $4.88M | -6.4% |
| FY2018 | Dec 31, 2018 | $5.21M | -22.0% |
| FY2017 | Dec 31, 2017 | $6.68M | +32.9% |
| FY2016 | Dec 31, 2016 | $5.03M | +307.0% |
| FY2015 | Dec 31, 2015 | $1.24M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | $1.00M | -25.0% |
| Q4 FY2019 | Dec 31, 2019 | $4.88M | +240.1% |
| Q4 FY2018 | Dec 31, 2018 | $5.21M | -22.0% |
| Q3 FY2018 | Sep 30, 2018 | $7.69K | -99.6% |
| Q2 FY2018 | Jun 30, 2018 | $1.33M | -23.4% |
| Q1 FY2018 | Mar 31, 2018 | $1.44M | +0.8% |
| Q4 FY2017 | Dec 31, 2017 | $6.68M | +32.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.98M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.74M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.42M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.03M | – |
See a number that looks wrong?